The EU’s medicines watchdog said on Friday that it expects Johnson and Johnson to submit an application for its coronavirus vaccine “shortly” after it published “promising” results from a large trial.
“We’ve just heard some promising results from the Janssen vaccine, which hope to be submitted shortly to us,” European Medicines Agency chief Emer Cooke told a press conference, referring to Johnson & Johnson’s European subsidiary Jansen-Cilag.
“This is currently subject to a rolling review which precedes the formal marketing authorisation application submission,” said Cooke.Read:It’s crucial we address COVID vaccine hesitancy among health workers. Here’s where to start
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
Read:Very little spread of coronavirus at kids’ day camps: study
EU regulator expects J&J vaccine application ‘shortly’ (2021, January 29)
retrieved 29 January 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.